Mechanism
Glucocorticoid receptor; Muscarinic M3; Beta-2 adrenergic
Assets acting on this target.
- Class
- Inhaled corticosteroid, long-acting muscarinic antagonist and long-acting beta2-agonist triple combination
- Notes
- hand ruling, audit finding #1861; Breztri held FIVE links, including a short-acting beta-2 row and a short-acting muscarinic row for a drug whose two bronchodilators are both long-acting. All are replaced by one row naming all three components; source: https://api.fda.gov/drug/label.json?search=openfda.brand_name:%22BREZTRI%22&limit=3